Medicare Enrolled
Dr. Joshua Strauss, M.D.
Hematology & Oncology · Springfield, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Strauss from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Strauss?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Strauss
Dr. Joshua Strauss is a hematology & oncology specialist in Springfield, NJ, with 17 years of NPI registration. Based on federal Medicare data, Dr. Strauss performed 1,343 Medicare services across 856 unique beneficiaries.
Between the years covered by Open Payments, Dr. Strauss received a total of $544,434 from 83 pharmaceutical and/or device companies across 1030 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Strauss is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ 1,343 Medicare services
$544,434 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,343
Medicare services
Bottom 41% in NJ for hematology & oncology
856
Unique beneficiaries
$94
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~79 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
415 | $72 | $247 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
344 | $103 | $363 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
154 | $145 | $488 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
137 | $68 | $240 |
| New patient office visit, complex (60-74 min) | 82 | $179 | $691 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
66 | $148 | $733 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
60 | $1 | $10 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
35 | $50 | $150 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
33 | $100 | $343 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
17 | $13 | $72 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$544,434
Total received (2018-2024)
Avg $77,776/year across 7 years
Top 1% in NJ for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
83
Companies
1,030
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$466,115 (85.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$52,584 (9.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,707 (4.7%)
Other
Charitable contributions, space rental, and other categories
$28 (0.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$144,618
2023
$190,757
2022
$86,479
2021
$103,943
2020
$16,592
2019
$1,355
2018
$688
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Exelixis Inc.
$53,304
Incyte Corporation
$27,676
BeiGene USA, Inc.
$20,623
Pharmacosmos Therapeutics Inc.
$17,548
Amgen Inc.
$17,173
PFIZER INC.
$4,125
SERVIER PHARMACEUTICALS LLC
$1,160
Genentech USA, Inc.
$1,056
ABBVIE INC.
$795
AstraZeneca Pharmaceuticals LP
$567
Novartis Pharmaceuticals Corporation
$59
Astellas Pharma US Inc
$55
Daiichi Sankyo Inc.
$55
Celgene Corporation
$49
Mirati Therapeutics, Inc.
$39
Merck Sharp & Dohme LLC
$39
E.R. Squibb & Sons, L.L.C.
$36
ARRAY BIOPHARMA INC
$33
Takeda Pharmaceuticals U.S.A., Inc.
$21
Agios Pharmaceuticals, Inc.
$20
Janssen Biotech, Inc.
$19
Ipsen Biopharmaceuticals, Inc
$19
Kyowa Kirin, Inc.
$19
Lilly USA, LLC
$19
TAIHO ONCOLOGY, INC.
$19
Sumitomo Pharma America, Inc.
$18
Janssen Pharmaceuticals, Inc
$16
Eisai Inc.
$15
SOBI, INC
$15
GlaxoSmithKline, LLC.
$14
PUMA BIOTECHNOLOGY, INC.
$13
Top 3 companies account for 70.3% of 2024 payments
All-time payments by company (2018-2024) ›
Incyte Corporation
$150,583
Exelixis Inc.
$137,876
Pharmacosmos Therapeutics Inc.
$78,836
BeiGene USA, Inc.
$57,089
Amgen Inc.
$44,042
Servier Pharmaceuticals LLC
$24,527
SERVIER PHARMACEUTICALS LLC
$10,957
Genentech USA, Inc.
$5,907
AstraZeneca Pharmaceuticals LP
$5,582
PFIZER INC.
$4,365
Kite Pharma, Inc.
$4,178
GENZYME CORPORATION
$3,711
AbbVie Inc.
$2,986
Agios Pharmaceuticals, Inc.
$2,876
ABBVIE INC.
$2,229
Jazz Pharmaceuticals Inc.
$2,110
Seagen Inc.
$1,301
Astellas Pharma US Inc
$657
Novartis Pharmaceuticals Corporation
$542
E.R. Squibb & Sons, L.L.C.
$473
SANOFI-AVENTIS U.S. LLC
$300
Janssen Biotech, Inc.
$267
Merck Sharp & Dohme Corporation
$251
Mirati Therapeutics, Inc.
$246
Janssen Pharmaceuticals, Inc
$184
Merck Sharp & Dohme LLC
$169
Lilly USA, LLC
$129
Celgene Corporation
$128
Daiichi Sankyo Inc.
$124
Takeda Pharmaceuticals U.S.A., Inc.
$121
Foundation Medicine, Inc.
$116
Celltrion USA Inc.
$114
AbbVie, Inc.
$92
GlaxoSmithKline, LLC.
$82
Taiho Oncology, Inc.
$74
Ipsen Biopharmaceuticals, Inc
$73
Eisai Inc.
$62
CTI BioPharma Corp.
$59
Sumitomo Pharma America, Inc.
$51
ARRAY BIOPHARMA INC
$50
Seattle Genetics, Inc.
$48
Regeneron Healthcare Solutions, Inc.
$43
Pharmacyclics LLC, An AbbVie Company
$41
Global Blood Therapeutics, Inc.
$41
Boehringer Ingelheim Pharmaceuticals, Inc.
$40
Bayer HealthCare Pharmaceuticals Inc.
$38
TAIHO ONCOLOGY, INC.
$37
Acera Surgical, Inc.
$37
Kyowa Kirin, Inc.
$33
Rigel Pharmaceuticals, Inc.
$29
Myovant Sciences Inc.
$29
Gilead Sciences, Inc.
$25
Lexicon Pharmaceuticals, Inc.
$23
Sirtex Medical Inc
$21
Spectrum Pharmaceuticals Inc.
$20
Secura Bio, Inc.
$19
Sobi, Inc
$19
W. L. Gore & Associates, Inc.
$18
JAZZ PHARMACEUTICALS INC.
$17
MorphoSys, US Inc.
$17
Karyopharm Therapeutics Inc.
$16
Janssen Scientific Affairs, LLC
$15
EUSA Pharma (US) LLC
$15
EMD Serono, Inc.
$15
Alexion Pharmaceuticals, Inc.
$15
Clovis Oncology, Inc.
$15
SOBI, INC
$15
Genmab U.S., Inc.
$15
Welch Allyn
$15
Deciphera Pharmaceuticals Inc.
$14
Helsinn Therapeutics (U.S.), Inc.
$14
Duchesnay USA Incorporated
$14
EISAI INC.
$14
Aurobindo Pharma USA, Inc.
$14
Apellis Pharmaceuticals, Inc.
$14
TerSera Therapeutics LLC
$13
Pharmacyclics LLC, an AbbVie Company
$13
PUMA BIOTECHNOLOGY, INC.
$13
Baxter Healthcare
$13
Novocure Inc.
$13
Octapharma USA, Inc.
$13
Heron Therapeutics, Inc.
$12
Advanced Accelerator Applications
$12
Top 3 companies account for 67.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · ALIMTA · Alecensa · Aranesp · Avastin · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CHANTIX · COSELA · CREON · CYRAMZA · Cabometyx · Cinvanti · Columvi · Creon · DARZALEX · DOPTELET · ELIQUIS · ELREXFIO · EPKINLY · ERLEADA · EXCLUDER Conformable AAA Endoprosthesis with Active Control · Empaveli · Enhertu · Erleada · FARYDAK · FOUNDATIONONE · FRUZAQLA · GAMIFANT · GAZYVA · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · Monoferric · NINLARO · None · Nplate · Nubeqa · OJJAARA · ONCASPAR · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Oncology · Onivyde · PADCEV · PAXLOVID · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · ROLVEDON · Restrata Wound Matrix · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · Siklos · Stivarga · Sylvant · TASIGNA · TECENTRIQ · TEPMETKO · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecartus · Tibsovo · Ultomiris · VEGZELMA · VENCLEXTA · VERZENIO · VYXEOS · Venclexta · Vonjo · Vyloy · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xermelo · Xospata · Yescarta · ZEJULA · Zevalin
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (86%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for hematology & oncology in NJ.
Geographic Context
Hematology & oncology specialists within 10 mi
602
Per 100K population
105.1
County median income
$100,117
Nearest hospital
OVERLOOK MEDICAL CENTER
2.0 mi
2.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Strauss is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of NJ peers, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Strauss experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Strauss performed 415 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Strauss receive payments from pharmaceutical companies?
Yes. Dr. Strauss received a total of $544,434 from 83 companies across 1,030 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Strauss's costs compare to other hematology & oncology specialists in Springfield?
Dr. Strauss's average Medicare payment per service is $94. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Strauss) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Springfield
Browse hematology & oncology specialists in Springfield ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NJ
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NJ
Which NJ hematology & oncology specialists receive the most from drug and device companies.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
Exelixis Inc. Payments to Doctors
See all physicians who received payments from Exelixis Inc.
By company
Pharmacosmos Therapeutics Inc. Payments to Doctors
See all physicians who received payments from Pharmacosmos Therapeutics Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology